The aim of the project is to elucidate molecular intra- and extracellular mechanisms of signaling modulating myeloid cells' immune responses. The project is supported by Innosuisse and has a translational goal aiming to pave a path to clinical applications.
This project is flanked by basic research projects i) investigating of the role of phosphoinositide 3-kinase (PI3K) signaling in allergy, metabolic control, obesity, diabetes and cancer; ii) developing and validation of novel chemical probes and degraders to dissect mechanisms of adverse effects in cancer and metabolism.
The successful candidate holds a PhD in Biochemistry, Molecular Biology, Immunology or another relevant Life-Science degree. Expertise in immunology, allergy, FACS (analysis and cell sorting), and mouse models is required. The candidate should hold a LTK module 1 (rodent course, Switzerland) or a FELASA function A/C/D (EU) certificate, including the required associated continued formation.
The candidate has an excellent proven track record in the publication of peer-reviewed scientific articles and/or patents.